Skip to main content

Table 2 Unadjusted mortality at 30 days, 5 years and 10 years stratified by RHD or non-RHD valve surgery

From: A review of outcome following valve surgery for rheumatic heart disease in Australia

Mortality number (%, 95 % CI) All valve surgery RHD valve surgery Non-RHD valve surgery RR* (95 % CI) (p value)
30 day 576/13866(4.2, 3.8 – 4.5) 35/1137(3.1, 2.2 – 4.3) 541/12729(4.3, 3.9 – 4.6) 1.38 (0.99 – 1.93)(0.058)
5 year 665/3821(17.4, 16.2 – 18.6) 54/353(15.3, 11.7 – 19.5) 611/3468(17.6, 16.4 – 18.9) 1.15 (0.89 – 1.49)(0.273)
10 year 96/254(37.8, 31.8 – 44.1) 7/28(25.0, 10.7 – 44.9) 89/226(39.4, 33.0 – 46.1) 1.58 (0.81 – 3.05)(0.139)
  1. *RR - Relative risk in RHD-related valve surgery patients compared with non-RHD surgery